Harvard Review of Psychiatry

Aims & Scope

The Harvard Review of Psychiatry is the authoritative source for scholarly reviews and perspectives on important topics in psychiatry.

Founded by the Harvard Medical School's Department of Psychiatry, the Harvard Review of Psychiatry features review papers that summarize and synthesize the key literature in a scholarly and clinically relevant manner.

Topics covered include: Schizophrenia and related disorders; Mood disorders; Personality disorders; Substance use disorders; Anxiety; Neuroscience; Psychosocial aspects of psychiatry; Ethics; Psychiatric education; and much more.

In addition, a Clinical Challenges section presents a case with discussion from a panel of experts.

Brief reviews are presented in topic-specific columns that include Cross-Cultural Psychiatry, History of Psychiatry, Ethics, and others.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	3.4
2024	2.50

SJR (SCImago Journal Rank)

Year	Value
2024	1.049

Quartile

Year	Value
2024	Q2

h-index

Year	Value
2024	94

Journal Rank

Year	Value
2024	4468

Journal Citation Indicator

Year	Value
2024	316

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• The Self-Medication Hypothesis of Substance Use Disorders: A Reconsideration and Recent Applications

  Citation: 2298

  Authors: Edward J.

• The Body Keeps the Score: Memory and the Evolving Psychobiology of Posttraumatic Stress

  Citation: 872

  Authors: Bessel A.

• The Use of Virtual Reality Technology in the Treatment of Anxiety and Other Psychiatric Disorders

  Citation: 622

  Authors: Jessica L., Brian E., Sae-Jin, Barbara O.

• Childhood Maltreatment, Emotional Dysregulation, and Psychiatric Comorbidities

  Citation: 515

  Authors: Yael, Julian D., Michael, Jean A.

• The Peptide That Binds

  Citation: 480

  Authors: Kai, Tina Marie

• Medication-Assisted Treatment of Opioid Use Disorder

  Citation: 462

  Authors: Hilary Smith

• Toward a Syndrome Model of Addiction: Multiple Expressions, Common Etiology

  Citation: 461

  Authors: Howard J., Debi A., Richard A., Rachel C., Anthony N., Michael V.

• The Glutamatergic Dysfunction Hypothesis for Schizophrenia

  Citation: 448

  Authors: Joseph T.

• Neurobiologic Processes in Drug Reward and Addiction

  Citation: 428

  Authors: Bryon

• Depression and Anxiety in Heart Failure: A Review

  Citation: 410

  Authors: Christopher M., Ana C., Ariana M., Hanna K., Jeff C.

---